Nicotinic receptor partial agonists modulate alcohol deprivation effect in C57BL/6J mice

Pharmacology Biochemistry and Behavior

Volumn 110, Issue , 2013, Pages 161-167

  Sajja, Ravi K ^a   Rahman, Shafiqur ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Alcohol; Alcohol deprivation effect; Mice; Nicotinic receptor; Relapse; Varenicline

Indexed keywords

ALCOHOL; CYTISINE; VARENICLINE;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG EFFECT; FLUID INTAKE; HABITUATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RELAPSE;

ANIMALIA; MUS;

ALCOHOL; ALCOHOL DEPRIVATION EFFECT; MICE; NICOTINIC RECEPTOR; RELAPSE; VARENICLINE;

ALCOHOL DRINKING; ALKALOIDS; ANIMALS; AZOCINES; BENZAZEPINES; MALE; MICE; MICE, INBRED C57BL; NICOTINIC AGONISTS; QUINOLIZINES; QUINOXALINES;

EID: 84881020892     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2013.07.009     Document Type: Article

References (45)

1. Barrick C, Connors GJ. Relapse prevention and maintaining abstinence in older adults with alcohol-use disorders. Drugs Aging 2002;19: 583-94.
2. Bell RL, Eiler II BJ, Cook JB, Rahman S. Nicotinic receptor ligands reduce ethanol intake by high alcohol-drinking HAD-2 rats. Alcohol 2009;43: 581-92.
3. Bito-Onon JJ, Simms JA, Chatterjee S, Holgate J, Bartlett SE. Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats. Addict Biol 2011;16: 440-9.
4. Butt CM, King NM, Stitzel JA, Collins AC. Interaction of the nicotinic cholinergic system with ethanol withdrawal. J Pharmacol Exp Ther 2004;308: 591-9. (Pubitemid 38134221)
5. Chatterjee S, Bartlett SE. Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders. CNS Neurol Disord Drug Targets 2010;9: 60-76.
6. Chatterjee S, Steensland P, Simms JA, Holgate J, Coe JW, Hurst RS, et al. Partial agonists of α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats. Neuropsychopharmacology 2011;36: 603-15.
7. Coe JW, Brooks PR, Vetelino MG, Wirtz MC, Arnold EP, Huang J, et al. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem 2005;48: 3474-7. (Pubitemid 40664098)
8. DiFranza JR, Guerrera MP. Alcoholism and smoking. J Stud Alcohol 1990;51: 130-5. (Pubitemid 20115516)
9. EricsonM, Löf E, Stomberg R, SöderpalmB. The smoking cessationmedication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system. J Pharmacol Exp Ther 2009;329: 225-30.
10. Funk D, Marinelli PW, Lê AD. Biological processes underlying co-use of alcohol and nicotine: neuronal mechanisms, cross-tolerance, and genetic factors. Alcohol Res Health 2006;29: 186-92.
11. Hauser SR, Getachew B, Oster SM, Dhaher R, Ding Z-M, Bell RL, et al. Nicotine modulates alcohol-seeking and relapse by alcohol-preferring (P) rats in a time dependent manner. Alcohol Clin Exp Res 2012;36: 43-54.
12. Hendrickson LM, Zhao-Shea R, Tapper AR. Modulation of ethanol drinking-in-the-dark by mecamylamine and nicotinic acetylcholine receptor agonists in C57BL/6J mice. Psychopharmacology (Berl) 2009;204: 563-72.
13. Hendrickson LM, Zhao-Shea R, Pang X, Gardner PD, Tapper AR. Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption. J Neurosci 2010;30: 10169-76.
14. Heyser CJ, Schulteis G, Durbin P, Koob GF. Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology 1998;18: 125-33. (Pubitemid 28026682)
15. Jerlhag E, Grøtli M, Luthman K, Svensson L, Engel JA. Role of subunit composition of central nicotinic acetylcholine receptors for the stimulatory and dopamine-enhancing effects of ethanol. Alcohol Alcohol 2006;41: 486-93. (Pubitemid 44404464)
16. Kamens HM, Andersen J, Piccioitto MR. Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice. Psychopharmacology (Berl) 2010;208: 613-26.
17. Khisti RT, Wolstenholme J, Shelton KL, Miles MF. Characterization of the ethanoldeprivation effect in substrains of C57BL/6 mice. Alcohol 2006;40: 119-26. (Pubitemid 46329323)
18. Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology 2010;35: 217-38.
19. Kuzmin A, Jerlhag E, Liljequist S, Engel J. Effects of subunit selective nACh receptors on operant ethanol self-administration and relapse-like ethanol-drinking behavior. Psychopharmacology (Berl) 2009;203: 99-108.
20. Larsson A, Engel JA. Neurochemical and behavioral studies on ethanol and nicotine interactions. Neurosci Biobehav Rev 2004;27: 713-20. (Pubitemid 38202247)
21. Lê A, Shaham Y. Neurobiology of relapse to alcohol in rats. Pharmacol Ther 2002;94: 137-56. (Pubitemid 34615963)
22. Lê AD, Li Z, Funk D, Shram M, Li TK, Shaham Y. Nicotine increases alcohol selfadministration and reinstates alcohol seeking in rats. Psychopharmacology (Berl) 2003;168: 216-21. (Pubitemid 36851182)
23. McBride WJ, Lê AD, Noronha A. Central nervous system mechanisms in alcohol relapse. Alcohol Clin Exp Res 2002;26: 280-6. (Pubitemid 34157765)
24. McKee SA, Harrison EL, O'Malley SS, Krishnan-Sarin S, Shi J, Tetrault JM, et al. Varenicline reduces alcohol self-administration in heavy-drinking smokers. Biol Psychiatry 2009;66: 185-90.
25. McKinzie DL, Nowak KL, Yorger L, McBride WJ, Murphy JM, Lumeng L, et al. The alcohol deprivation effect in the alcohol preferring P rat under free-drinking and operant conditions. Alcohol Clin Exp Res 1998;22: 1170-6. (Pubitemid 28409014)
26. Melendez RI, Middaugh LD, Kalivas PW. Development of an alcohol deprivation and escalation effect in C57BL/6J mice. Alcohol Clin Exp Res 2006;30: 2017-25. (Pubitemid 44749529)
27. Mihalak KB, Carroll FI, Luetje CW. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol 2006;70: 801-5. (Pubitemid 44268437)
28. O'Connor EC, Parker D, Rollema H, Mead AN. The α4β2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats. Psychopharmacology (Berl) 2010;208: 365-76.
29. Papke RL, Heinemann SF. Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit. Mol Pharmacol 1994;45: 142-9. (Pubitemid 24042293)
30. Papke RL, Wecker L, Stitzel JA. Activation and inhibition of mouse muscle and neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther 2010;333: 501-18.
31. Rahman S. Brain nicotinic receptors as emerging targets for drug addiction: neurobiology to translational research. Prog Mol Biol Transl Sci 2011;98: 349-65.
32. Rahman S, Prendergast MA. Cholinergic receptor system as a target for treating alcohol abuse and dependence. Recent Pat CNS Drug Discov 2012;7: 145-50.
33. Rezvani AH, Slade S, Wells C, Petro A, Lumeng L, Li TK, et al. Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats. Psychopharmacology (Berl) 2010;211: 161-74.
34. Rodd-Henricks ZA, McKinzie DL, Shaikh SR, Murphy JM, McBride WJ, Lumeng L, et al. Alcohol deprivation effect is prolonged in the alcohol preferring (P) rat after repeated deprivations. Alcohol Clin Exp Res 2000;24: 8-16. (Pubitemid 30062774)
35. Rollema H, Shrikhande A, Ward KM, Tingley 3rd FD, Coe JW, O'Neill BT, et al. Preclinical properties of alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence. Br J Pharmacol 2010;60(2): 334-45.
36. Sajja RK, Rahman S. Lobeline and cytisine reduce voluntary ethanol drinking behavior in male C57BL/6J mice. Prog Neuropsychopharmacol Biol Psychiatry 2011;35: 257-64.
37. Sajja RK, Rahman S. Neuronal nicotinic receptor ligands modulate chronic nicotineinduced ethanol consumption in C57BL/6J mice. Pharmacol Biochem Behav 2012;102: 36-43.
38. Sajja RK, Rahman S. Cytisine modulates chronic voluntary ethanol consumption and ethanol-induced striatal up-regulation of ΔFosB in mice. Alcohol 2013;47: 299-307.
39. Sajja RK, Dwivedi C, Rahman S. Nicotinic ligands modulate ethanol-induced dopamine function in mice. Pharmacology 2010;86: 168-73.
40. Sanchis-Segura C, Borchardt T, Vengeliene V, Zghoul T, Bachteler D, Gass P, et al. Involvement of the AMPA receptor GluR-C subunit in alcohol-seeking behavior and relapse. J Neurosci 2006;26: 1231-8. (Pubitemid 43239573)
41. Spanagel R, Hölter SM. Long-term alcohol self-administration with repeated alcohol deprivation phases: an animal model of alcoholism? Alcohol Alcohol 1999;34: 231-43. (Pubitemid 29213717)
42. Sparta DR, Ferraro III FM, Fee JR, Knapp DJ, Breese GR, Thiele TE. The alcohol deprivation effect in C57BL/6J mice is observed using operant self-administration procedures and is modulated by CRF-1 receptor signaling. Alcohol Clin Exp Res 2009;33: 31-42.
43. Steensland P, Simms JA, Holgate J, Richards JK, Bartlett SE. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc Natl Acad Sci U S A 2007;104: 12518-23. (Pubitemid 47206170)
44. Weiss F, Porrino LJ. Behavioral neurobiology of alcohol addiction: recent advances and challenges. J Neurosci 2002;22: 3332-7. (Pubitemid 37465737)
45. Wouda JA, Riga D, De Vries W, Stegeman M, van Mourik Y, Schetters D, et al. Varenicline attenuates cue-induced relapse to alcohol but not nicotine seekingwhile reducing inhibitory response control. Psychopharmacology (Berl) 2011;216: 267-77.